Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds

Core Viewpoint - Enveric Biosciences, Inc. has successfully closed the exercise of certain outstanding warrants, allowing for the purchase of 426,390 shares at specified exercise prices [1] Group 1: Company Actions - The company announced the closing of the exercise of warrants to purchase up to an aggregate of 426,390 shares [1] - The warrants were originally issued in February 2025 and September 2025 [1] - The exercise prices for the shares are set at $36.00 and $10.98 per share [1]